Molecular Platform Shows Promise for Detecting Asymptomatic Malaria Cases
A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.
Read MorePosted by CLP Edit Staff | Oct 24, 2025 | Emerging & Zoonotic Diseases |
A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.
Read MorePosted by CLP Edit Staff | Oct 23, 2025 | Lung Cancer |
The permit enables the company to offer its PROphetNSCLC test to physicians and patients across New York State, completing nationwide availability.
Read MorePosted by CLP Edit Staff | Oct 23, 2025 | Cancer |
German laboratory brings tumor-informed MRD testing to European market through licensing agreement with Quest Diagnostics subsidiary.
Read MorePosted by CLP Edit Staff | Oct 22, 2025 | Cervical (HPV) |
New automated workflow combines at-home sampling with robotic lab processing.
Read MorePosted by CLP Edit Staff | Oct 20, 2025 | Bioreactors |
PhysioMimix Core combines single-organ, multi-organ, and high-throughput configurations in one microphysiological system.
Read More